首页> 外文期刊>亚洲核医学杂志 >放射性微球局部治療表淺轉移性腫瘤18例臨床觀察
【24h】

放射性微球局部治療表淺轉移性腫瘤18例臨床觀察

机译:放射性微球局部治疗表浅转移性肿瘤18例临床观察

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Objective To evaluate the therapeutic effects of radionuclide-labled microsphere by intratumoral injection into 18 patients with superficial matastasis tumor for treatment. Methods 18 patients with superficial matastasis were treated with radionuclide-labled microsphere (90 Y-GTMS and 32 P-GTMS) by multi-point intratumoral injection. Each injection dose was 11.1 ~ 18.5MBq/g (tumor). Results 1 patient vas relieved completely, 9 were relieved partly, 5 were improved and 3 kept stable. The total rate of relief and virtual value were 55.6% and 83.3% respectively. Conclusion Topical treatment by using radionuclide may help diminish the tumor, control its progress and ease the symptoms. Thus it can be used as a supplement of routin treatment of tumors and it should do some work in therapy of malignant tumors in late stages.
机译:目的探讨放射性核素封装微球的治疗效果通过肿瘤内注射成18例肤质腐蚀性肿瘤治疗。方法通过多点肿瘤内注射用放射性核素封闭的微球(90 Y-GTMS和32 P-GTMS)治疗18例浅表腐败患者。每种注射剂量为11.1〜18.5Mbq / g(肿瘤)。结果1患者VA完全松弛,9分均放松,5种改善,3保持稳定。救济和虚拟值的总速率分别为55.6%和83.3%。结论采用放射性核素的局部处理可能有助于减少肿瘤,控制其进展并缓解症状。因此,它可以用作肿瘤的常规治疗的补充,并且应该在晚期治疗恶性肿瘤治疗中进行一些工作。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号